Nektar TherapeuticsNKTRNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank0
3Y CAGR-79.2%
5Y CAGR-60.1%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-79.2%/yr
vs -3.0%/yr prior
5Y CAGR
-60.1%/yr
Recent deceleration
Acceleration
-76.2pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $196000.00 | -99.4% |
| 2024 | $30.69M | -16.3% |
| 2023 | $36.64M | +69.4% |
| 2022 | $21.64M | -13.1% |
| 2021 | $24.90M | +27.8% |
| 2020 | $19.48M | -8.9% |
| 2019 | $21.37M | -12.4% |
| 2018 | $24.41M | -20.1% |
| 2017 | $30.55M | +1.1% |
| 2016 | $30.21M | - |